Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry

Niels P. G. Hoedemaker; Peter Damman; Jan Paul Ottervanger; Jan Henk E. Dambrink; A. T. Marcel Gosselink; Elvin Kedhi; Evelien Kolkman; Robbert J. de Winter; Arnoud W. J. van't Hof

doi:10.1093/ehjcvp/pvy030

Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry

Niels P. G. Hoedemaker, Peter Damman, Jan Paul Ottervanger, Jan Henk E. Dambrink, A. T. Marcel Gosselink, Elvin Kedhi, Evelien Kolkman, Robbert J. de Winter, Arnoud W. J. van't Hof

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	127-138
Number of pages	12
Journal	European Heart Journal-Cardiovascular Pharmacotherapy
Volume	5
Issue number	3
DOIs	https://doi.org/10.1093/ehjcvp/pvy030
Publication status	Published - Jul 2019

Keywords

Proton-pump inhibitors
Acute coronary syndrome
Dual antiplatelet therapy
Registry
Outcomes
ACUTE MYOCARDIAL-INFARCTION
ST-SEGMENT ELEVATION
DUAL-ANTIPLATELET THERAPY
BASE-LINE CHARACTERISTICS
PLATELET INHIBITION
CLINICAL-OUTCOMES
CONCOMITANT USE
EUROPEAN-SOCIETY
TASK-FORCE
2017 ESC

Access to Document

10.1093/ehjcvp/pvy030

Cite this

Hoedemaker, N. P. G., Damman, P., Ottervanger, J. P., Dambrink, J. H. E., Gosselink, A. T. M., Kedhi, E., Kolkman, E., de Winter, R. J., & van't Hof, A. W. J. (2019). Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. European Heart Journal-Cardiovascular Pharmacotherapy, 5(3), 127-138. https://doi.org/10.1093/ehjcvp/pvy030

Hoedemaker, Niels P. G. ; Damman, Peter ; Ottervanger, Jan Paul ; Dambrink, Jan Henk E. ; Gosselink, A. T. Marcel ; Kedhi, Elvin ; Kolkman, Evelien ; de Winter, Robbert J. ; van't Hof, Arnoud W. J. / Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors : a five-year experience from a single-centre observational registry. In: European Heart Journal-Cardiovascular Pharmacotherapy. 2019 ; Vol. 5, No. 3. pp. 127-138.

@article{22b5170c40d94d27a70bcb7eb2d48f0c,

title = "Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry",

keywords = "Proton-pump inhibitors, Acute coronary syndrome, Dual antiplatelet therapy, Registry, Outcomes, ACUTE MYOCARDIAL-INFARCTION, ST-SEGMENT ELEVATION, DUAL-ANTIPLATELET THERAPY, BASE-LINE CHARACTERISTICS, PLATELET INHIBITION, CLINICAL-OUTCOMES, CONCOMITANT USE, EUROPEAN-SOCIETY, TASK-FORCE, 2017 ESC",

author = "Hoedemaker, {Niels P. G.} and Peter Damman and Ottervanger, {Jan Paul} and Dambrink, {Jan Henk E.} and Gosselink, {A. T. Marcel} and Elvin Kedhi and Evelien Kolkman and {de Winter}, {Robbert J.} and {van't Hof}, {Arnoud W. J.}",

year = "2019",

month = jul,

doi = "10.1093/ehjcvp/pvy030",

language = "English",

volume = "5",

pages = "127--138",

journal = "European Heart Journal-Cardiovascular Pharmacotherapy",

issn = "2055-6837",

publisher = "Oxford University Press",

number = "3",

}

Hoedemaker, NPG, Damman, P, Ottervanger, JP, Dambrink, JHE, Gosselink, ATM, Kedhi, E, Kolkman, E, de Winter, RJ & van't Hof, AWJ 2019, 'Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 5, no. 3, pp. 127-138. https://doi.org/10.1093/ehjcvp/pvy030

Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors : a five-year experience from a single-centre observational registry. / Hoedemaker, Niels P. G.; Damman, Peter; Ottervanger, Jan Paul; Dambrink, Jan Henk E.; Gosselink, A. T. Marcel; Kedhi, Elvin; Kolkman, Evelien; de Winter, Robbert J.; van't Hof, Arnoud W. J.

In: European Heart Journal-Cardiovascular Pharmacotherapy, Vol. 5, No. 3, 07.2019, p. 127-138.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors

T2 - a five-year experience from a single-centre observational registry

AU - Hoedemaker, Niels P. G.

AU - Damman, Peter

AU - Ottervanger, Jan Paul

AU - Dambrink, Jan Henk E.

AU - Gosselink, A. T. Marcel

AU - Kedhi, Elvin

AU - Kolkman, Evelien

AU - de Winter, Robbert J.

AU - van't Hof, Arnoud W. J.

PY - 2019/7

Y1 - 2019/7

KW - Proton-pump inhibitors

KW - Acute coronary syndrome

KW - Dual antiplatelet therapy

KW - Registry

KW - Outcomes

KW - ACUTE MYOCARDIAL-INFARCTION

KW - ST-SEGMENT ELEVATION

KW - DUAL-ANTIPLATELET THERAPY

KW - BASE-LINE CHARACTERISTICS

KW - PLATELET INHIBITION

KW - CLINICAL-OUTCOMES

KW - CONCOMITANT USE

KW - EUROPEAN-SOCIETY

KW - TASK-FORCE

KW - 2017 ESC

U2 - 10.1093/ehjcvp/pvy030

DO - 10.1093/ehjcvp/pvy030

M3 - Article

VL - 5

SP - 127

EP - 138

JO - European Heart Journal-Cardiovascular Pharmacotherapy

JF - European Heart Journal-Cardiovascular Pharmacotherapy

SN - 2055-6837

IS - 3

ER -

Hoedemaker NPG, Damman P, Ottervanger JP, Dambrink JHE, Gosselink ATM, Kedhi E et al. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. European Heart Journal-Cardiovascular Pharmacotherapy. 2019 Jul;5(3):127-138. https://doi.org/10.1093/ehjcvp/pvy030